<DOC>
	<DOCNO>NCT01162837</DOCNO>
	<brief_summary>This study determine use BEAM device reduces sign symptom mild-to-moderate acne .</brief_summary>
	<brief_title>Safety &amp; Effectiveness BEAM Device Mild-to-moderate Acne</brief_title>
	<detailed_description />
	<criteria>1 . Age 15 year old either gender racial/ethnic group . 2 . At least 8 acne inflammatory lesion ( see section 9 ) treatment control area . 3 . Presence clinicallyevident facial acne mildtomoderate severity ( score 24 Global Acne Severity Scale , see ) 4 . Subjects must generally good health . 5 . Subjects must able willing comply requirement protocol . 1 . Oral retinoid use within six month entry study . 2 . Systemic acne therapy ( oral antibiotic ) within 2 week entry study . 3 . Topical acne therapy ( retinoids , antibiotic ) within 1 week entry study . 4 . Microdermabrasion superficial chemical peel site treat within 2 month entry study . 5 . Subjects history dermabrasion laser resurface site treat . 6 . Use topical lipid absorb substance ( Clinac AC ) within 1 week entry study . 7 . Noncompliant subject . 8 . Subjects significant medical history concurrent illness/condition investigator ( ) feel safe study participation . 9 . Subjects use alcoholbased topical solution `` exfoliate '' agent within 1 week entry study . 10 . Subjects history frequent herpes simplex infection face clinical evidence active herpes simplex infection . 11 . Pregnant nursing female . 12 . Subjects know photosensitivity disorder felt investigator preclude safe inclusion study . 13 . Subjects history significant postinflammatory hyperpigmentation site acne lesion .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Acne</keyword>
</DOC>